Prognosis and Predictors of ACL Reconstruction: A Multicenter Cohort Study
Prognosis and Predictors of ACL Reconstruction: A Multicenter Cohort Study
批准号:
8679064
负责人:
Kurt Paul Spindler
金额:
$19.4万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-25 至 2015-09-17
关键词:
AddressAgeAllograftingAnterior Cruciate LigamentCartilage injuryCharacteristicsClinicalClinical TrialsCohort StudiesComplexContralateralDataDecision MakingDegenerative polyarthritisEnrollmentEthnic OriginExcisionFailureFemaleFunding OpportunitiesFutureGenderGrantHealthIncidenceIndividualInferiorInjuryIpsilateralKnowledgeLateral meniscus structureLesionLife StyleLocationMeasurementMedialMeniscus structure of jointModelingOperative Surgical ProceduresOrthopedicsOutcomeOutcome StudyPainPatient Outcomes AssessmentsPatientsPhysiciansPopulationPreventionProspective StudiesPublishingQuestionnairesResearchRiskRisk FactorsSample SizeSeveritiesSigns and SymptomsSiteSmokingSmoking StatusSourceSportsSurgeonSymptomsTelephoneTendon structureTestingTimeWorkanterior cruciate ligament reconstructionanterior cruciate ligament rupturearticular cartilagecohortdesignfollow-upgraft failurehamstringimprovedinstrumentmodifiable riskoutcome forecastparent grantpredictive modelingprospectivepublic health relevancerepairedtime interval
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Injury to the anterior cruciate ligament (ACL) results in a threat to an active lifestyle and exposes the patient to risk of early osteoarthritis. ACL reconstruction is typically chosen by individuals to allow a return to their previous work and sports activities. The results of primary ACL reconstruction have in general been good at restoring functional stability, but patients' long-term outcome remains unknown. The Multicenter Orthopaedic Outcomes Network (MOON) is an established consortium designed to enroll and longitudinally follow a population cohort of ACL reconstructed patients to determine the modifiable predictors (or risk factors) of long-term outcomes of ACL reconstruction in order to establish patient-specific predictive models of clinically important outcomes. The objective of this prospective multicenter cohort of ACL reconstructions is to identify both the long-term prognosis and the potentially modifiable predictors of symptoms of osteoarthritis (OA), sports function, activity and general health through validated patient- reported outcomes, and incidence of ACL reconstruction graft and/or contralateral ACL failures. Our initial grant (R01 AR053684) allowed us to enroll over 2,300 patients and obtain both 2 and 6 year follow-up on this cohort. At both time points, we have been able to obtain a minimum of 85% follow-up using validated patient-reported outcome questionnaires and 93% via phone follow-up. Two of the original three Aims from the parent grant will be advanced in this competitive revision, 1) validated patient-reported outcomes of sports function, activity level, general health, and symptomatic OA, and 2) ACL graft or contralateral ACL failures. The objective of this revision is to complete 6 year follow-up on an additional unfunded MOON cohort of 1251 ACL reconstructed patients (with an already completed 86% 2 year follow-up rate) in the last 1.5 years of the parent grant (4/2014 - 8/2015). This would increase our existing sample size by ~ 50%, and would enable us to build the most comprehensive "personalized" models to address detailed contributions of meniscus and articular cartilage injury and treatment (and their interactions) to several patient reported outcomes and OA symptoms. Furthermore, we would be the first to perform complex multivariable predictive modeling of ACL graft and contralateral ACL failure. The additional variables incorporated into longer 6 year time interval is particularly
important for establishing the longer-term outcomes and symptoms of OA and incidence of both ipsilateral and contralateral ACL tears.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Applying Evidence Based Principles to Personalized Medicine
-
批准号:9913253
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2020
-
负责人:Kurt Paul Spindler
-
依托单位:
BEAR-MOON: A Two Arm Noninferiority Blinded Randomized Clinical Trial Comparing ACL Repair with BEAR Device vs. Standard of Care Autograft Patellar Tendon ACL Reconstruction
-
批准号:9986663
-
项目类别:
-
资助金额:$113.57万
-
财政年份:2018
-
负责人:Kurt Paul Spindler
-
依托单位:
BEAR-MOON: A Two Arm Noninferiority Blinded Randomized Clinical Trial Comparing ACL Repair with BEAR Device vs. Standard of Care Autograft Patellar Tendon ACL Reconstruction
-
批准号:9751779
-
项目类别:
-
资助金额:$121.72万
-
财政年份:2018
-
负责人:Kurt Paul Spindler
-
依托单位:
BEAR-MOON: A Two Arm Noninferiority Blinded Randomized Clinical Trial Comparing ACL Repair with BEAR Device vs. Standard of Care Autograft Patellar Tendon ACL Reconstruction
-
批准号:10476991
-
项目类别:
-
资助金额:$115.3万
-
财政年份:2018
-
负责人:Kurt Paul Spindler
-
依托单位:
2012 Musculoskeletal Biology & Bioengineering Gordon Research Conference
-
批准号:8317859
-
项目类别:
-
资助金额:$2.1万
-
财政年份:2012
-
负责人:Kurt Paul Spindler
-
依托单位:
Enabling ACL Repair Using Proprietary Collagen Device
-
批准号:7746312
-
项目类别:
-
资助金额:$15.78万
-
财政年份:2009
-
负责人:Kurt Paul Spindler
-
依托单位:
Prognosis and Predictors of ACL Reconstruction: A Multicenter Cohort Study
-
批准号:8515742
-
项目类别:
-
资助金额:$55.76万
-
财政年份:2006
-
负责人:Kurt Paul Spindler
-
依托单位:
Prognosis and Predictors of ACL Reconstruction: A Multicenter Cohort Study
-
批准号:9763447
-
项目类别:
-
资助金额:$58.99万
-
财政年份:2006
-
负责人:Kurt Paul Spindler
-
依托单位:
Prognosis and Predictors of ACL Reconstruction: A Multicenter Cohort Study
-
批准号:8146971
-
项目类别:
-
资助金额:$65.78万
-
财政年份:2006
-
负责人:Kurt Paul Spindler
-
依托单位:
Prognosis and Predictors of ACL Reconstruction: A Multicenter Cohort Study
-
批准号:8734207
-
项目类别:
-
资助金额:$57.37万
-
财政年份:2006
-
负责人:Kurt Paul Spindler
-
依托单位:
Prognosis and Predictors of ACL Reconstruction: A Multicenter Cohort Study
-
批准号:9146271
-
项目类别:
-
资助金额:$63.87万
-
财政年份:2006
-
负责人:Kurt Paul Spindler
-
依托单位:
Prognosis and Predictors of ACL Reconstruction: A Multicenter Cohort Study
-
批准号:7292756
-
项目类别:
-
资助金额:$40.78万
-
财政年份:2006
-
负责人:Kurt Paul Spindler
-
依托单位:
Prognosis and Predictors of ACL Reconstruction: A Multicenter Cohort Study
-
批准号:7211197
-
项目类别:
-
资助金额:$41.46万
-
财政年份:2006
-
负责人:Kurt Paul Spindler
-
依托单位:
Prognosis and Predictors of ACL Reconstruction: A Multicenter Cohort Study
-
批准号:7485043
-
项目类别:
-
资助金额:$40.37万
-
财政年份:2006
-
负责人:Kurt Paul Spindler
-
依托单位:
Prognosis and Predictors of ACL Reconstruction: A Multicenter Cohort Study
-
批准号:9329269
-
项目类别:
-
资助金额:$64.3万
-
财政年份:2006
-
负责人:Kurt Paul Spindler
-
依托单位:
Prognosis and Predictors of ACL Reconstruction: A Multicenter Cohort Study
-
批准号:8323986
-
项目类别:
-
资助金额:$64.8万
-
财政年份:2006
-
负责人:Kurt Paul Spindler
-
依托单位:
Prognosis and Predictors of ACL Reconstruction: A Multicenter Cohort Study
-
批准号:7677887
-
项目类别:
-
资助金额:$42.99万
-
财政年份:2006
-
负责人:Kurt Paul Spindler
-
依托单位:
Prognosis and Predictors of ACL Reconstruction: A Multicenter Cohort Study
-
批准号:8040731
-
项目类别:
-
资助金额:$70.13万
-
财政年份:2006
-
负责人:Kurt Paul Spindler
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: